ChrysCapital Pares Down its Stake in Corona
23 Jun 2026
US$ 20.00
ChrysCapital has sold part of its stake in India-listed Corona Remedies Ltd (Corona) and clocked 7.5 bn rupees (US$79.1...
Related Publications
The world has been spellbound by the promises of the technology sector. In the West, the IPO by Space Exploration...
HongShan Capital Group and Gaorong Ventures have invested US$100 m each in the initial funding round of ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.